| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioma | 26 | 2012 | 1963 | 2.360 |
Why?
|
| ErbB Receptors | 11 | 2013 | 2295 | 1.400 |
Why?
|
| Brain Neoplasms | 23 | 2013 | 4849 | 1.360 |
Why?
|
| Astrocytes | 13 | 2004 | 368 | 1.200 |
Why?
|
| Nerve Tissue Proteins | 9 | 2010 | 1491 | 1.000 |
Why?
|
| Oligodendroglia | 9 | 2001 | 96 | 0.910 |
Why?
|
| Glioblastoma | 10 | 2013 | 1797 | 0.900 |
Why?
|
| Organoplatinum Compounds | 3 | 2011 | 702 | 0.850 |
Why?
|
| Triterpenes | 2 | 2013 | 61 | 0.850 |
Why?
|
| Autophagy | 5 | 2011 | 927 | 0.790 |
Why?
|
| Neoplasm Proteins | 9 | 2010 | 3230 | 0.730 |
Why?
|
| Apoptosis | 13 | 2015 | 7591 | 0.720 |
Why?
|
| Loss of Heterozygosity | 5 | 2007 | 602 | 0.690 |
Why?
|
| Carrier Proteins | 7 | 2010 | 2022 | 0.660 |
Why?
|
| Neovascularization, Pathologic | 5 | 2012 | 1547 | 0.630 |
Why?
|
| Calcium-Binding Proteins | 4 | 2007 | 545 | 0.630 |
Why?
|
| src Homology Domains | 5 | 2007 | 124 | 0.600 |
Why?
|
| Cell Division | 11 | 2010 | 2489 | 0.580 |
Why?
|
| Stem Cells | 9 | 2003 | 1213 | 0.520 |
Why?
|
| Mice, Nude | 12 | 2013 | 4307 | 0.520 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2013 | 142 | 0.500 |
Why?
|
| Cisplatin | 6 | 2015 | 2432 | 0.460 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2010 | 1439 | 0.460 |
Why?
|
| STAT5 Transcription Factor | 2 | 2012 | 214 | 0.460 |
Why?
|
| Signal Transduction | 15 | 2013 | 11965 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2003 | 135 | 0.450 |
Why?
|
| Genes, Tumor Suppressor | 5 | 2008 | 1064 | 0.450 |
Why?
|
| Cell Nucleus | 5 | 2015 | 1620 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 80 | 0.430 |
Why?
|
| Tumor Cells, Cultured | 10 | 2013 | 5395 | 0.420 |
Why?
|
| Animals | 46 | 2013 | 59536 | 0.410 |
Why?
|
| Guanylate Cyclase | 1 | 2011 | 74 | 0.400 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2013 | 2359 | 0.400 |
Why?
|
| Ki-67 Antigen | 2 | 2004 | 666 | 0.400 |
Why?
|
| Gonanes | 1 | 2011 | 45 | 0.390 |
Why?
|
| Phosphotyrosine | 1 | 2011 | 111 | 0.390 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2012 | 810 | 0.390 |
Why?
|
| Protein Isoforms | 4 | 2010 | 842 | 0.380 |
Why?
|
| Meningioma | 2 | 2003 | 289 | 0.380 |
Why?
|
| Galectin 3 | 1 | 2012 | 138 | 0.370 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2011 | 703 | 0.370 |
Why?
|
| Rats | 16 | 2007 | 6086 | 0.370 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2013 | 419 | 0.370 |
Why?
|
| Piperazines | 2 | 2009 | 2101 | 0.360 |
Why?
|
| G2 Phase | 1 | 2010 | 206 | 0.360 |
Why?
|
| BRCA1 Protein | 1 | 2013 | 493 | 0.360 |
Why?
|
| Endocytosis | 3 | 2010 | 225 | 0.360 |
Why?
|
| Cell Cycle | 4 | 2012 | 2084 | 0.360 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 3 | 2008 | 212 | 0.350 |
Why?
|
| Wnt Proteins | 1 | 2012 | 397 | 0.350 |
Why?
|
| Meningeal Neoplasms | 2 | 2003 | 441 | 0.340 |
Why?
|
| Wnt Signaling Pathway | 1 | 2012 | 430 | 0.340 |
Why?
|
| Macrolides | 1 | 2009 | 62 | 0.340 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2011 | 591 | 0.330 |
Why?
|
| STAT3 Transcription Factor | 2 | 2013 | 1121 | 0.330 |
Why?
|
| Mice | 26 | 2013 | 34495 | 0.330 |
Why?
|
| Blotting, Western | 7 | 2013 | 3536 | 0.330 |
Why?
|
| Amino Acid Sequence | 9 | 2012 | 4233 | 0.320 |
Why?
|
| Protein Structure, Tertiary | 6 | 2011 | 1487 | 0.310 |
Why?
|
| Cell Differentiation | 9 | 2002 | 4078 | 0.310 |
Why?
|
| Cell Line, Tumor | 15 | 2015 | 14551 | 0.310 |
Why?
|
| beta Catenin | 1 | 2012 | 688 | 0.310 |
Why?
|
| Antineoplastic Agents | 8 | 2011 | 14289 | 0.300 |
Why?
|
| Cells, Cultured | 13 | 2012 | 5637 | 0.300 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2004 | 854 | 0.300 |
Why?
|
| Ubiquitin | 3 | 2004 | 344 | 0.300 |
Why?
|
| Protein Binding | 8 | 2012 | 3438 | 0.300 |
Why?
|
| Proteins | 2 | 2008 | 1963 | 0.280 |
Why?
|
| Pyrimidines | 2 | 2009 | 3518 | 0.280 |
Why?
|
| Oligopeptides | 4 | 2010 | 429 | 0.280 |
Why?
|
| Exons | 4 | 2006 | 1328 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2013 | 327 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2015 | 2488 | 0.280 |
Why?
|
| Xenopus Proteins | 1 | 2007 | 185 | 0.280 |
Why?
|
| Phosphorylation | 8 | 2015 | 4804 | 0.270 |
Why?
|
| Endopeptidases | 1 | 2007 | 220 | 0.270 |
Why?
|
| Cytoskeleton | 2 | 2004 | 267 | 0.260 |
Why?
|
| Humans | 60 | 2021 | 261506 | 0.260 |
Why?
|
| Proteome | 2 | 2007 | 561 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2012 | 8873 | 0.250 |
Why?
|
| Proteomics | 3 | 2008 | 1380 | 0.250 |
Why?
|
| Alternative Splicing | 2 | 2004 | 584 | 0.230 |
Why?
|
| DNA, Neoplasm | 3 | 2003 | 1910 | 0.230 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2012 | 1062 | 0.230 |
Why?
|
| Cerebral Cortex | 3 | 2004 | 621 | 0.230 |
Why?
|
| Neuroglia | 3 | 2000 | 223 | 0.230 |
Why?
|
| src-Family Kinases | 2 | 2012 | 478 | 0.230 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2003 | 3552 | 0.230 |
Why?
|
| Phosphoproteins | 2 | 2007 | 1152 | 0.220 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2009 | 923 | 0.220 |
Why?
|
| Cyclin B | 1 | 2003 | 63 | 0.220 |
Why?
|
| Cell Nucleolus | 1 | 2003 | 89 | 0.220 |
Why?
|
| Optic Nerve | 5 | 2001 | 133 | 0.220 |
Why?
|
| Membrane Proteins | 4 | 2010 | 2819 | 0.220 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 2 | 2003 | 57 | 0.220 |
Why?
|
| Cell Survival | 4 | 2013 | 3045 | 0.210 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2003 | 129 | 0.210 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2010 | 534 | 0.210 |
Why?
|
| Genomics | 2 | 2013 | 2738 | 0.200 |
Why?
|
| Karyopherins | 1 | 2003 | 136 | 0.200 |
Why?
|
| Fibroblast Growth Factor 2 | 4 | 1999 | 223 | 0.200 |
Why?
|
| RNA, Small Interfering | 5 | 2012 | 2216 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2002 | 181 | 0.200 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2000 | 502 | 0.200 |
Why?
|
| Protein Multimerization | 2 | 2012 | 240 | 0.190 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2003 | 310 | 0.190 |
Why?
|
| Cell Culture Techniques | 2 | 2001 | 598 | 0.190 |
Why?
|
| Cell Separation | 2 | 2001 | 612 | 0.190 |
Why?
|
| Genes, p53 | 2 | 1995 | 1090 | 0.190 |
Why?
|
| Mutation | 7 | 2013 | 15179 | 0.190 |
Why?
|
| Biomedical Research | 1 | 2008 | 806 | 0.190 |
Why?
|
| Genetic Markers | 1 | 2003 | 974 | 0.190 |
Why?
|
| Acetylcholinesterase | 1 | 2000 | 23 | 0.190 |
Why?
|
| Cell Line | 7 | 2007 | 5114 | 0.190 |
Why?
|
| Mitosis | 1 | 2003 | 615 | 0.180 |
Why?
|
| Oligodendroglioma | 2 | 2013 | 106 | 0.180 |
Why?
|
| Autophagy-Related Protein 5 | 2 | 2010 | 46 | 0.180 |
Why?
|
| Neurites | 1 | 2000 | 63 | 0.180 |
Why?
|
| Genetic Heterogeneity | 1 | 2002 | 318 | 0.180 |
Why?
|
| Community Health Services | 1 | 2021 | 126 | 0.180 |
Why?
|
| Protein Transport | 2 | 2012 | 734 | 0.180 |
Why?
|
| Cell Movement | 5 | 2013 | 2466 | 0.180 |
Why?
|
| Neurology | 1 | 2001 | 113 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2008 | 1823 | 0.170 |
Why?
|
| Medical Oncology | 2 | 2014 | 1423 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 3639 | 0.170 |
Why?
|
| Animals, Newborn | 4 | 2012 | 1338 | 0.170 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 568 | 0.170 |
Why?
|
| Neoplasm Transplantation | 3 | 2011 | 1519 | 0.170 |
Why?
|
| Down-Regulation | 1 | 2004 | 2074 | 0.170 |
Why?
|
| Platelet-Derived Growth Factor | 4 | 1994 | 157 | 0.170 |
Why?
|
| Molecular Sequence Data | 7 | 2010 | 6089 | 0.170 |
Why?
|
| X Chromosome | 1 | 2000 | 339 | 0.170 |
Why?
|
| Chromosome Deletion | 1 | 2003 | 1005 | 0.170 |
Why?
|
| Ganglia, Spinal | 1 | 2000 | 237 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2002 | 488 | 0.160 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 862 | 0.160 |
Why?
|
| Precipitin Tests | 3 | 2003 | 329 | 0.160 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 2 | 2019 | 2370 | 0.160 |
Why?
|
| Gene Deletion | 2 | 2000 | 1442 | 0.160 |
Why?
|
| Neuropeptides | 1 | 1999 | 154 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2000 | 402 | 0.160 |
Why?
|
| Cricetinae | 3 | 2004 | 706 | 0.150 |
Why?
|
| Astrocytoma | 1 | 2000 | 321 | 0.150 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2003 | 189 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2011 | 3821 | 0.140 |
Why?
|
| Sequence Deletion | 4 | 2012 | 875 | 0.140 |
Why?
|
| Internet | 1 | 2001 | 706 | 0.140 |
Why?
|
| Muscle Development | 1 | 1996 | 88 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 1 | 1999 | 492 | 0.140 |
Why?
|
| Cell Proliferation | 5 | 2012 | 7226 | 0.140 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2015 | 621 | 0.140 |
Why?
|
| Breast Neoplasms | 3 | 2013 | 15694 | 0.140 |
Why?
|
| Neoplasm Staging | 2 | 2009 | 13658 | 0.140 |
Why?
|
| Organs at Risk | 1 | 2019 | 514 | 0.130 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2003 | 1248 | 0.130 |
Why?
|
| Gene Dosage | 2 | 2008 | 829 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 5 | 2013 | 3203 | 0.130 |
Why?
|
| DNA, Complementary | 3 | 2002 | 869 | 0.130 |
Why?
|
| Drug Therapy, Combination | 2 | 2011 | 2315 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2001 | 1335 | 0.130 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2015 | 73 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 3 | 2011 | 3981 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2002 | 1498 | 0.130 |
Why?
|
| Cell Adhesion | 2 | 2011 | 1008 | 0.130 |
Why?
|
| Imatinib Mesylate | 2 | 2009 | 1665 | 0.130 |
Why?
|
| Binding Sites | 2 | 2012 | 2171 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 3 | 2012 | 2314 | 0.120 |
Why?
|
| Transplantation, Heterologous | 3 | 2011 | 1082 | 0.120 |
Why?
|
| Genome, Human | 3 | 2012 | 1869 | 0.120 |
Why?
|
| Physical Chromosome Mapping | 1 | 2013 | 73 | 0.120 |
Why?
|
| Benzamides | 2 | 2009 | 1832 | 0.120 |
Why?
|
| Alleles | 1 | 2000 | 2437 | 0.120 |
Why?
|
| Radiotherapy Dosage | 2 | 2019 | 3842 | 0.120 |
Why?
|
| Nerve Regeneration | 2 | 1991 | 105 | 0.110 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1996 | 445 | 0.110 |
Why?
|
| Nuclear Export Signals | 1 | 2012 | 10 | 0.110 |
Why?
|
| E-Box Elements | 1 | 2012 | 12 | 0.110 |
Why?
|
| Nuclear Localization Signals | 1 | 2012 | 46 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 2 | 2004 | 4367 | 0.110 |
Why?
|
| Cyanoacrylates | 1 | 2013 | 41 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 1555 | 0.110 |
Why?
|
| Disease Progression | 4 | 2012 | 6682 | 0.110 |
Why?
|
| Survival Rate | 4 | 2012 | 12221 | 0.110 |
Why?
|
| RNA, Messenger | 3 | 2012 | 6150 | 0.110 |
Why?
|
| Genes, erbB-1 | 3 | 2008 | 101 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2015 | 370 | 0.110 |
Why?
|
| Trichosanthes | 1 | 2012 | 1 | 0.110 |
Why?
|
| Gene Expression Profiling | 3 | 2008 | 5159 | 0.110 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2012 | 157 | 0.110 |
Why?
|
| Models, Biological | 3 | 2009 | 3254 | 0.100 |
Why?
|
| TCF Transcription Factors | 1 | 2012 | 35 | 0.100 |
Why?
|
| bcl-X Protein | 1 | 2012 | 196 | 0.100 |
Why?
|
| Soluble Guanylyl Cyclase | 1 | 2011 | 15 | 0.100 |
Why?
|
| Threonine | 2 | 2015 | 161 | 0.100 |
Why?
|
| Chickens | 1 | 2012 | 523 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2012 | 234 | 0.100 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2011 | 22 | 0.100 |
Why?
|
| Microsatellite Repeats | 2 | 2003 | 575 | 0.100 |
Why?
|
| Dimerization | 2 | 2003 | 304 | 0.100 |
Why?
|
| Biomarkers, Tumor | 2 | 2008 | 10331 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 3 | 2015 | 3101 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2012 | 163 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 518 | 0.100 |
Why?
|
| RNA Interference | 2 | 2013 | 1408 | 0.100 |
Why?
|
| HeLa Cells | 2 | 2007 | 1643 | 0.100 |
Why?
|
| Central Nervous System | 2 | 1991 | 436 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 161 | 0.100 |
Why?
|
| Biological Clocks | 1 | 1991 | 45 | 0.100 |
Why?
|
| Phosphopeptides | 1 | 2011 | 65 | 0.100 |
Why?
|
| Sequence Alignment | 2 | 2004 | 844 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 1993 | 769 | 0.100 |
Why?
|
| Protease Inhibitors | 1 | 2002 | 210 | 0.090 |
Why?
|
| Beclin-1 | 1 | 2010 | 85 | 0.090 |
Why?
|
| Gene Frequency | 2 | 2003 | 1163 | 0.090 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 278 | 0.090 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2019 | 2104 | 0.090 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2010 | 63 | 0.090 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 324 | 0.090 |
Why?
|
| Blotting, Northern | 2 | 2002 | 682 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2012 | 215 | 0.090 |
Why?
|
| Skull | 1 | 2011 | 231 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 460 | 0.090 |
Why?
|
| Cyclin D1 | 1 | 2012 | 576 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2008 | 1678 | 0.090 |
Why?
|
| Brain | 5 | 2010 | 4113 | 0.090 |
Why?
|
| Cytoplasm | 2 | 2004 | 652 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2012 | 5270 | 0.080 |
Why?
|
| Actins | 2 | 2003 | 608 | 0.080 |
Why?
|
| Fibroblast Growth Factors | 1 | 1990 | 257 | 0.080 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 133 | 0.080 |
Why?
|
| Lymphocytes | 2 | 2003 | 1234 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 368 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 1217 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2013 | 1489 | 0.080 |
Why?
|
| Fibroblasts | 2 | 2012 | 1682 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2015 | 1493 | 0.080 |
Why?
|
| Neoplasms | 5 | 2021 | 15193 | 0.080 |
Why?
|
| Neurofibromin 1 | 1 | 2008 | 85 | 0.080 |
Why?
|
| Neurosurgical Procedures | 2 | 2011 | 609 | 0.080 |
Why?
|
| Telemedicine | 1 | 2014 | 471 | 0.080 |
Why?
|
| DNA Modification Methylases | 1 | 2008 | 172 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 997 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2019 | 1833 | 0.080 |
Why?
|
| Drug Synergism | 1 | 2011 | 1313 | 0.080 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 1742 | 0.080 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2006 | 566 | 0.080 |
Why?
|
| Iron | 1 | 2010 | 376 | 0.080 |
Why?
|
| Phenotype | 2 | 2012 | 6295 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 4143 | 0.080 |
Why?
|
| Neuropilin-1 | 1 | 2007 | 40 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2010 | 1732 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2006 | 1756 | 0.070 |
Why?
|
| DNA Repair Enzymes | 1 | 2008 | 237 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 1070 | 0.070 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2007 | 60 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 191 | 0.070 |
Why?
|
| Behavior, Animal | 1 | 2010 | 709 | 0.070 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 1999 | 104 | 0.070 |
Why?
|
| Oncolytic Virotherapy | 1 | 2009 | 280 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2003 | 663 | 0.070 |
Why?
|
| Wound Healing | 1 | 2011 | 815 | 0.070 |
Why?
|
| Time Factors | 5 | 2003 | 12926 | 0.070 |
Why?
|
| Adenine | 1 | 2009 | 631 | 0.070 |
Why?
|
| Pyridines | 1 | 2013 | 1244 | 0.070 |
Why?
|
| Female | 12 | 2019 | 141928 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2006 | 931 | 0.070 |
Why?
|
| Point Mutation | 2 | 2006 | 769 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 2 | 2004 | 2483 | 0.070 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2005 | 82 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 702 | 0.070 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2007 | 216 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 10035 | 0.070 |
Why?
|
| Paclitaxel | 2 | 2009 | 1996 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 208 | 0.060 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2005 | 205 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 848 | 0.060 |
Why?
|
| Acyltransferases | 1 | 2004 | 62 | 0.060 |
Why?
|
| Antibodies | 1 | 2008 | 838 | 0.060 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 293 | 0.060 |
Why?
|
| Oocytes | 1 | 2007 | 414 | 0.060 |
Why?
|
| Dinucleotide Repeats | 1 | 2003 | 10 | 0.060 |
Why?
|
| Neurons | 3 | 2010 | 2287 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2005 | 342 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 803 | 0.060 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2003 | 83 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2006 | 7548 | 0.060 |
Why?
|
| Tumor Protein p73 | 1 | 2003 | 105 | 0.060 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2003 | 14 | 0.060 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2003 | 72 | 0.060 |
Why?
|
| Male | 10 | 2011 | 123000 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 2054 | 0.060 |
Why?
|
| Tyrosine | 1 | 2004 | 498 | 0.060 |
Why?
|
| Cyclin A | 1 | 2003 | 47 | 0.060 |
Why?
|
| Tubulin | 1 | 2003 | 169 | 0.060 |
Why?
|
| HCT116 Cells | 1 | 2003 | 348 | 0.060 |
Why?
|
| Lasers | 1 | 2003 | 198 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2003 | 367 | 0.060 |
Why?
|
| Electric Impedance | 1 | 2003 | 100 | 0.060 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2003 | 111 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2003 | 333 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 161 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2003 | 118 | 0.050 |
Why?
|
| CDC2 Protein Kinase | 1 | 2003 | 176 | 0.050 |
Why?
|
| Epitopes | 1 | 2004 | 685 | 0.050 |
Why?
|
| Transfection | 2 | 2007 | 2944 | 0.050 |
Why?
|
| Microtubules | 1 | 2003 | 270 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2003 | 362 | 0.050 |
Why?
|
| Base Sequence | 2 | 2013 | 4917 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2008 | 29902 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 1993 | 151 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2003 | 249 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 6942 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 311 | 0.050 |
Why?
|
| CD2 Antigens | 1 | 2000 | 31 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 1999 | 5319 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2004 | 850 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2000 | 32 | 0.050 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2000 | 52 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2002 | 699 | 0.050 |
Why?
|
| DNA Repair | 1 | 2008 | 1872 | 0.050 |
Why?
|
| DNA Helicases | 1 | 2003 | 434 | 0.050 |
Why?
|
| Hybrid Cells | 1 | 2000 | 128 | 0.050 |
Why?
|
| Adenoviridae | 2 | 2009 | 1459 | 0.050 |
Why?
|
| Diffusion of Innovation | 1 | 2001 | 160 | 0.050 |
Why?
|
| Data Display | 1 | 2000 | 49 | 0.050 |
Why?
|
| Xenopus | 1 | 2000 | 219 | 0.050 |
Why?
|
| Gene Library | 1 | 2000 | 294 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2008 | 1443 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 198 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 205 | 0.040 |
Why?
|
| Myelin Sheath | 2 | 1991 | 149 | 0.040 |
Why?
|
| Carcinogenicity Tests | 1 | 1999 | 70 | 0.040 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 1999 | 16 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1999 | 73 | 0.040 |
Why?
|
| Tumor Stem Cell Assay | 1 | 1999 | 231 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2003 | 669 | 0.040 |
Why?
|
| Aged | 5 | 2013 | 70117 | 0.040 |
Why?
|
| Research | 1 | 2001 | 415 | 0.040 |
Why?
|
| Automation | 1 | 2019 | 151 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2008 | 2669 | 0.040 |
Why?
|
| Culture Media | 1 | 1999 | 319 | 0.040 |
Why?
|
| Adult | 5 | 2013 | 77950 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 4053 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2000 | 575 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 4938 | 0.040 |
Why?
|
| Software | 1 | 2005 | 1321 | 0.040 |
Why?
|
| Testis | 1 | 2002 | 717 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 2045 | 0.040 |
Why?
|
| Aneuploidy | 1 | 1999 | 369 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2003 | 4821 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 1999 | 423 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2003 | 1245 | 0.040 |
Why?
|
| Transcription Factor HES-1 | 1 | 1996 | 49 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 3154 | 0.040 |
Why?
|
| Cell Fusion | 1 | 1996 | 80 | 0.040 |
Why?
|
| Multiple Sclerosis | 2 | 1991 | 349 | 0.040 |
Why?
|
| Calcium | 1 | 2003 | 1537 | 0.040 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2003 | 962 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2015 | 4757 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 1471 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 11538 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 1999 | 487 | 0.030 |
Why?
|
| Adolescent | 2 | 2008 | 31252 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 1996 | 254 | 0.030 |
Why?
|
| Middle Aged | 4 | 2008 | 86204 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2001 | 1085 | 0.030 |
Why?
|
| Muscles | 1 | 1996 | 416 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1996 | 246 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2000 | 1694 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2003 | 2063 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 323 | 0.030 |
Why?
|
| Octamer Transcription Factor-6 | 1 | 1993 | 4 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2000 | 1506 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1993 | 52 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2006 | 2341 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 1996 | 383 | 0.030 |
Why?
|
| Schwann Cells | 1 | 1993 | 75 | 0.030 |
Why?
|
| Putamen | 1 | 2003 | 26 | 0.030 |
Why?
|
| Cell Death | 1 | 1995 | 671 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2010 | 5710 | 0.030 |
Why?
|
| Culture Techniques | 1 | 2003 | 132 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 5178 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2013 | 143 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 370 | 0.030 |
Why?
|
| Caudate Nucleus | 1 | 2003 | 43 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 1996 | 622 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2002 | 43 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 1993 | 562 | 0.030 |
Why?
|
| Aurora Kinases | 1 | 2012 | 189 | 0.030 |
Why?
|
| Heterozygote | 1 | 1995 | 1020 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 1993 | 429 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 3343 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 289 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2002 | 220 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 212 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2019 | 37905 | 0.030 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 197 | 0.030 |
Why?
|
| Fetal Hemoglobin | 1 | 1991 | 33 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2002 | 143 | 0.020 |
Why?
|
| Lymphokines | 1 | 2002 | 272 | 0.020 |
Why?
|
| Aurora Kinase A | 1 | 2012 | 202 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2010 | 45 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 1996 | 1143 | 0.020 |
Why?
|
| Transferrin | 1 | 2010 | 78 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 2927 | 0.020 |
Why?
|
| Molecular Mimicry | 1 | 2010 | 72 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 694 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 8865 | 0.020 |
Why?
|
| Biomarkers | 1 | 2002 | 5047 | 0.020 |
Why?
|
| Peptide Library | 1 | 2010 | 158 | 0.020 |
Why?
|
| Dopamine Antagonists | 1 | 2010 | 52 | 0.020 |
Why?
|
| Up-Regulation | 1 | 1996 | 2450 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 1995 | 1046 | 0.020 |
Why?
|
| Cell Communication | 1 | 1993 | 509 | 0.020 |
Why?
|
| Mitogens | 1 | 1990 | 75 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 1 | 2009 | 62 | 0.020 |
Why?
|
| Dopamine Agonists | 1 | 2010 | 85 | 0.020 |
Why?
|
| Kinetics | 1 | 1993 | 2049 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2010 | 238 | 0.020 |
Why?
|
| Entropy | 1 | 2008 | 37 | 0.020 |
Why?
|
| Growth Substances | 1 | 1990 | 300 | 0.020 |
Why?
|
| DNA Replication | 1 | 1993 | 744 | 0.020 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2009 | 163 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 1996 | 1664 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1990 | 553 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 1489 | 0.020 |
Why?
|
| Models, Neurological | 1 | 1990 | 225 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2003 | 1869 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 475 | 0.020 |
Why?
|
| Phagosomes | 1 | 2008 | 72 | 0.020 |
Why?
|
| Tubulin Modulators | 1 | 2008 | 65 | 0.020 |
Why?
|
| Ceramides | 1 | 2008 | 95 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2004 | 16273 | 0.020 |
Why?
|
| DNA Damage | 1 | 1995 | 1954 | 0.020 |
Why?
|
| Algorithms | 1 | 2019 | 3890 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 891 | 0.020 |
Why?
|
| Butadienes | 1 | 2007 | 35 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 1990 | 741 | 0.020 |
Why?
|
| Oxides | 1 | 2008 | 211 | 0.020 |
Why?
|
| Arsenicals | 1 | 2008 | 201 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 1516 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2008 | 691 | 0.020 |
Why?
|
| Motor Activity | 1 | 2010 | 693 | 0.020 |
Why?
|
| Virus Replication | 1 | 2009 | 709 | 0.020 |
Why?
|
| Dacarbazine | 1 | 2008 | 485 | 0.020 |
Why?
|
| Prognosis | 1 | 2003 | 21713 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2002 | 1533 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 943 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2007 | 886 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2006 | 760 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 1265 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 12873 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2007 | 750 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 6009 | 0.010 |
Why?
|
| Child | 1 | 2004 | 29154 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 7551 | 0.010 |
Why?
|
| Nitriles | 1 | 2007 | 906 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 2508 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 4549 | 0.010 |
Why?
|
| Aging | 1 | 1990 | 1582 | 0.010 |
Why?
|
| Tumor Burden | 1 | 2007 | 1987 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 2283 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 1879 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2001 | 641 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 7222 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2006 | 9244 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2001 | 1616 | 0.010 |
Why?
|